Jan G Zijlstra
Overview
Explore the profile of Jan G Zijlstra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
165
Citations
1522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moser J, Zijlstra J, van Meurs M
Intensive Care Med
. 2025 Feb;
PMID: 39934317
No abstract available.
2.
Jou-Valencia D, Volbeda M, Zijlstra J, Kootstra-Ros J, Moser J, van Meurs M, et al.
BMC Nephrol
. 2024 Jan;
25(1):43.
PMID: 38287305
Background: NGAL and Cystatin C (CysC) as biomarkers for the early detection of AKI are subject to both pathophysiological, as well as patient related heterogeneity. The aim of this study...
3.
Volbeda M, Jou-Valencia D, van den Heuvel M, Zijlstra J, Franssen C, van der Voort P, et al.
Clin Exp Med
. 2022 Nov;
23(4):1003-1014.
PMID: 36396750
The dominant ICU admission diagnosis of COVID-19 patients is respiratory insufficiency, but 32-57% of hospitalized COVID-19 patients develop acute kidney injury (COVID-AKI). The renal histopathological changes accompanying COVID-AKI are not...
4.
Verhaeghe J, Dhaese S, De Corte T, Vander Mijnsbrugge D, Aardema H, Zijlstra J, et al.
BMC Med Inform Decis Mak
. 2022 Aug;
22(1):224.
PMID: 36008808
Background: Beta-lactam antimicrobial concentrations are frequently suboptimal in critically ill patients. Population pharmacokinetic (PopPK) modeling is the golden standard to predict drug concentrations. However, currently available PopPK models often lack...
5.
Zijlstra G, Zijlstra H, Zijlstra J
Crit Care Med
. 2022 Feb;
50(3):e334.
PMID: 35191889
No abstract available.
6.
Molema G, Zijlstra J, van Meurs M, Kamps J
Nat Rev Nephrol
. 2021 Oct;
18(2):95-112.
PMID: 34667283
Microvascular endothelial cells in the kidney have been a neglected cell type in sepsis-induced acute kidney injury (sepsis-AKI) research; yet, they offer tremendous potential as pharmacological targets. As endothelial cells...
7.
Smit M, van Meurs M, Zijlstra J
Scand J Surg
. 2021 Oct;
111(1):14574969211030128.
PMID: 34605332
Background And Objective: Intra-abdominal hypertension is frequently present in critically ill patients and is an independent predictor for mortality. In this narrative review, we aim to provide a comprehensive overview...
8.
Zijlstra J, van Meurs M, Moser J
Crit Care Med
. 2021 Sep;
49(10):e1047.
PMID: 34529625
No abstract available.
9.
Benoit D, van der Zee E, Darmon M, Reyners A, Metaxa V, Mokart D, et al.
Ann Intensive Care
. 2021 Jul;
11(1):120.
PMID: 34331626
Background: Whether Intensive Care Unit (ICU) clinicians display unconscious bias towards cancer patients is unknown. The aim of this study was to compare the outcomes of critically ill patients with...
10.
Volbeda M, Jou-Valencia D, van den Heuvel M, Knoester M, Zwiers P, Pillay J, et al.
Crit Care
. 2021 Jun;
25(1):202.
PMID: 34112226
Background: The mechanisms driving acute kidney injury (AKI) in critically ill COVID-19 patients are unclear. We collected kidney biopsies from COVID-19 AKI patients within 30 min after death in order...